GEVOGevo, Inc.
Price
-38%1YEnd-of-day closes, not the intraday tick.
Mostly good, one thing to check: the market
Quality strong, nothing alarming, growing in the filings, the market against it.
Charts
As reported to the SEC, without any scoring.
Gevo, Inc. (GEVO) reported revenue of $47M in Q2 2026 (quarter ended Jun 30, 2026), up 7.1% from the same quarter a year earlier. That came with a gross margin of 43% and net loss of $177M. For the full year FY2025, revenue was $161M (+849% year on year) and net income −$34M. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 26, 2026On August 20, 2026, the Board of Directors of Gevo, Inc., a Delaware corporation (the “Company”) appointed Greg Hanselman as the Company’s Chief Operating Officer, effective immediately.Director or officer change · Form 8-K
- Aug 6, 2026Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026.Earnings release · press release
- Jul 16, 2026Effective as of August 20, 2026, the Board of Directors (the “Board”) of Gevo, Inc. (“Gevo” or the “Company”) approved the appointment of Todd Werpy to the Board as a Class II director, with a current term that will expire at the annual meeting of stockholders to be held in 2027.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Specialty Chemicals
Ranks #33 of 33 by RyuScore